Cerebrospinal fluid GABA levels in chronic migraine with and without depression

Brain Research

Volumn 1090, Issue 1, 2006, Pages 197-201

  Vieira, D S S ^a   Naffah Mazacoratti, M G ^a   Zukerman, E ^a   Senne Soares, C A ^a   Alonso, E O ^a   Faulhaber, M H W ^a   Cavalheiro, E A ^a   Peres, M F P ^a  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Cerebrospinal fluid; Chronic migraine; Depression; GABA; Pathophysiology

Indexed keywords

4 AMINOBUTYRIC ACID;

ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; TRANSFORMED MIGRAINE;

BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIGRAINE DISORDERS; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 33744526918     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.03.051     Document Type: Article

References (50)

1. Alborch E., Torregrosa G., Terrasa J.C., and Estrada C. GABA receptors mediate cerebral vasodilation in the unanesthetized goat. Brain Res. 321 1 (1984) 103-110
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), APA Press, Washington, DC
3. Anwar N., and Mason P.F.J. Two actions of gamma-aminobutyric acid (GABA) on the responses of isolated basilar artery from the rabbit. Br. Med. Pharmacol. 75 (1982) 177-181
4. Barbelivien A., Noel C., MacKenzie E.T., and Dauphin F. Cerebrovascular evidence for a GABAergic modulation of the cholinergic vasodilatatory basalocortical system in the rat. Brain Res. 834 1-2 (1999) 223-227
5. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
6. Berrettini W.H., Nurnberger Jr. J.I., Hare T.A., Simmons-Alling S., Gershon E.S., and Post R.M. Reduced plasma and CSFgamma-aminobutyric acid in affective illness: effect of lithium carbonate. Biol. Psychiatry 18 (1983) 185-194
7. Berrettini W.H., Nurnberger Jr. J.I., Hare T.A., Simmons-Alling S., and Gershon E.S. CSF GABA in euthymic manic-depressive patients and controls. Biol. Psychiatry 21 (1986) 844-846
8. Brambilla P., Perez J., Barale F., Schettini G., and Soares J.C. GABAergic dysfunction min mood disorders. Mol. Psychiatry 8 (2003) 721-737
9. Cavalheiro E.A., Fernandes M.J., Turski L., and Naffah-Mazzacoratti M.G. Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus. Epilepsia 35 1 (1994) 1-11
10. Cheetham S.C., Crompton M.R., Katona C.L.E., and Horton R.W. Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res. 443 (1988) 272-280
11. Dennis T., Beauchemin V., and Lavoie N. Differential effects of olfactory bulbectomy on GABAA and GABAB receptors in the rat brain. Pharmacol. Biochem. Behav. 46 (1993) 77-82
12. Drugan R.C., Morrow A.L., Weizman R., Deutsch S.I., Crawlay J.N., et al. Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Res. 487 (1989) 45-51
13. Emrich H.M., von Zerssen D., Kissling W., Moller H.J., and Windorfer A. Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch. Psychiatr. Nervenkr. 229 (1980) 1-16
14. Fergus A., and Lee K.S. GABAergic regulation of cerebral microvascular tone in the rat. J. Cereb. Blood Flow Metab. 17 9 (1997) 992-1003
15. Ferkany J.W., Smith L.A., Seifert W.E., Caprioli R.M., and Enna S.J. Measurement of gamma-aminobutyric acid (GABA) in blood. Life Sci. 22 (1978) 2121-2128
16. Gener R.H., Fairbanks L., Anderson G.M., Young J.G., Scheiner M., Linnoila M., et al. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. Am. J. Psychiatry 141 (1984) 1533-1540
17. Gold B.I., Browers Jr. M.B., Roth R.H., and Sweeney D.W. GABA levels in CSF of patient with psychiatric disorders. Am. J. Psychiatry 137 (1980) 362-364
18. Grove J., Schechter P.J., Hanke N.F., deSmet Y., Agid Y., Tell G., et al. Concentrations gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparation of suboccipital and lumbar sampling. J. Neurochem. 39 (1982) 1618-1622
19. Jancsar S.M., and Leonard B.E. Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat. Prog. Neuropsychopharmacol. Boil Psychiatry 8 (1984) 263-269
20. Joly D., Lloyd K.G., Pichat P., and Sanger D.J. Correlation between the behavioral effect of desipramine and GABAB receptor regulation in the olfactory bulbectomized rat. Br. J. Pharmacol. 90 (1987) 125
21. Kasa K., Otsuki S., Yamamoto M., Sato M., Kuroda H., and Ogawa N. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid id depressive disorders. Biol. Psychiatry 17 (1982) 877-883
22. Kavuk I., Yavuz A., Cetindere U., Agelink M.W., and Diener H.C. Epidemiology of chronic daily headache. Eur. J. Med. Res. 8 6 (2003) 236-240
23. Kelly J.P., Wrynn A.S., and Leonard B.E. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol. Ther. 74 (1997) 299-316
24. Kowa H., Shimomura T., and Takahashi K. Platelet gamma-aminobutyric acid levels in migraine and tension-type headache. Headache 32 (1992) 229-232
25. Lloyd K.G., and Pichat P. Decrease in GABAB binding to the frontal cortex of olfactory bulbectomized rats. Br. J. Pharmacol. 87 (1986) 36
26. Lloyd K.G., Morselli P.L., and Bartholini G. GABA and affective disorders. Med. Biol. 65 (1987) 159-165
27. Lloyd K.G., Zivkovic B., Sanger D., Depoortere H., and Bartholini G. A novel antidepressant GABAergic agent. Activity in models for antidepressant drugs and psychopharmacological profile. J. Pharmacol. Exp. Ther. 241 (1987) 245-250
28. Lloyd K.G., Zivkovic B., Scatton B., Morselli P.L., and Bartholini G. The GABAergic hypothesis of depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 13 (1989) 341-351
29. Loscher W. Relationship between GABA concentrations in cerebrospinal fluid and seizure exci6tability. J. Neurochem. 38 (1982) 293-295
30. Loscher W., and Frey H.H. Transport of GABA at the blood-CSF interface. J. Neurochem. 38 (1982) 1072-1079
31. Mathew N.T., Ravishankar K., and Sanin L.C. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46 5 (1996) 1226-1230 (May)
32. Mercante J.P.P., Peres M.F.P., Guendler V., Zukerman E., and Bernik M.A. Depression in chronic migraine. Arq. Neuro-Psiquiatr. 63 2-A (2005) 217-220
33. Northoff G., Steinke R., Czcervenka C., Krause R., Ulrich S., Danos P., et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J. Neurol. Neurosurg. Psychiatry 67 (1999) 445-450
34. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. 2nd ed. Cephalalgia Suppl. 1 (2004) 9-160
35. Petty F. Plasma concentrations of gamma-amonobutyric acid and mood disorders: a blood test for manic depressive disease. Clin. Chem. 40 (1994) 296-302
36. Petty F. Gaba and mood disorders: a brief review and hypothesis. J. Affect. Disord. 34 (1995) 275-281
37. Petty F., and Schlesser M.A. Plasma GABA in affective illness. A preliminary investigation. J. Affect. Disord. 3 (1981) 339-343
38. Petty F., and Sherman A.D. GABAergig modulation of learned helplessness. Pharmacol. Biochem. Behav. 15 (1981) 567-570
39. Petty F., and Sherman A.D. Plasma GABA in affective illness. J. Affect. Disord. 6 (1984) 131-138
40. Perry E.K., Gibson P.H., Blessed G., Perry G.H., and Tholinson B.E. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J. Neurol. Sci. 34 (1977) 247-265
41. Petty F., Krammer G.L., Dunnam D., and Rush A.J. Plasma GABA in mood disorders. Psychopharmacol. Bull. 26 (1990) 157-161
42. Petty F., Kramer G.L., Fulton M., Moeller F.G., and Rush A.J. Low plasma GABA is a trait-like maker for bipolar illness. Neuropsychopharmacology 9 (1993) 125-132
43. Petty F., Kramer G.L., Fulton M., Davis L., and Rush A.J. Stability of plasma GABA at four-year follow-up in patients with primary unipolar depression. Biol. Psychiatry 37 (1995) 806-810
44. Post R.M., Ballenger J.C., Hare T.A., Goodwin F.K., Lake C.R., and Jimerson D.C. Cerebrospinal fluid GABA in normals and patients with affective disorders. Brain Res. Bull. 5 Suppl. 9 (1980) 755-759
45. Quattrone A., Bono F., Oliveri R.L., Gambardella A., Pirritano D., Labate A., et al. Cerebral venous thrombosis and isolated intracranial hypertension without papilledema in CDH. Neurology 57 1 (2001) 31-36 (Jul 10)
46. Sherman A.D., and Petty F. Neurochemical basis of the action of antidepressants on learned helplessness. Behav. Neural Biol. 30 (1980) 119-134
47. Shian I.-Shin., and Yathanm L.N. GABA function in mood disorders: an update and critical review. Life Sci. 63 (1998) 1289-1303
48. Silberstein S.D., Lipton R.B., and Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47 (1996) 871-875
49. Tunnicliff G., and Malatynska E. Central GABAergic systems and depressive illness. Neurochem. Res. 28 (2003) 965-976
50. Welch K.M.A., Chabi E., Bartosh K., Achar V.S., and Meyer J.S. Cerebrospinal fluid γ aminobutyric acid levels in migraine. Br. Med. J. 3 (1975) 516-517